1 IN 2
IS TOO MANY

1 in 2 of us will be diagnosed with cancer by age 85.
Donate now

Striving for a cancer-free future

Anti-EGFR drug conjugates for the treatment of colorectal and breast cancer

Lead researcher

A/Prof Hui Gan, Prof Andrew Scott, Prof John Mariadason, A/Prof Elgene Lim, Prof Niall Tebbutt

Institution
La Trobe University

Tumour type:
Colorectal, breast

Years funded
2017-2019

This project explores exciting new drugs for colorectal and breast cancer patients which are highly targeted and very potent. The results could lead to better treatments for these patients.

Funding Body

Cancer Council Victoria Research Grant